DSK Co., Ltd. (KOSDAQ:109740)
5,090.00
+95.00 (1.90%)
At close: Jul 10, 2026
DSK Co., Ltd. Revenue
DSK Co., Ltd. had revenue of 4.90B KRW in the quarter ending March 31, 2026, with 58.34% growth. This brings the company's revenue in the last twelve months to 44.99B, up 113.42% year-over-year. In the year 2025, DSK Co., Ltd. had annual revenue of 43.18B with 90.72% growth.
Revenue (ttm)
44.99B
Revenue Growth
+113.42%
P/S Ratio
2.83
Revenue / Employee
408.96M
Employees
110
Market Cap
127.47B
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 43.18B | 20.54B | 90.72% |
| Dec 31, 2024 | 22.64B | -48.86B | -68.34% |
| Dec 31, 2023 | 71.50B | 23.27B | 48.24% |
| Dec 31, 2022 | 48.23B | -1.56B | -3.13% |
| Dec 31, 2021 | 49.79B | 17.20B | 52.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Avaco | 381.65B |
| Keeps Biopharma | 188.94B |
| HyVision System. | 176.25B |
| DMS Co.,Ltd. | 135.95B |
| C&G Hi Tech | 132.41B |
| FNS TECH. | 73.55B |
| PIE Co., LTD. | 67.68B |
| HB SOLUTION | 57.41B |